Tetsuo Akimoto

5.0k total citations
252 papers, 3.1k citations indexed

About

Tetsuo Akimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Tetsuo Akimoto has authored 252 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Pulmonary and Respiratory Medicine, 81 papers in Oncology and 68 papers in Surgery. Recurrent topics in Tetsuo Akimoto's work include Head and Neck Cancer Studies (49 papers), Advanced Radiotherapy Techniques (44 papers) and Lung Cancer Treatments and Mutations (31 papers). Tetsuo Akimoto is often cited by papers focused on Head and Neck Cancer Studies (49 papers), Advanced Radiotherapy Techniques (44 papers) and Lung Cancer Treatments and Mutations (31 papers). Tetsuo Akimoto collaborates with scholars based in Japan, United States and Singapore. Tetsuo Akimoto's co-authors include Norio Mitsuhashi, Hideyuki Sakurai, Lara Buchmiller, Nancy Hunter, Atsushi Motegi, Sadamoto Zenda, Hideo Niibe, K.A. Mason, K.K. Ang and L. Milas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Tetsuo Akimoto

236 papers receiving 3.1k citations

Peers

Tetsuo Akimoto
Robert S. Malyapa United States
Mohan Suntharalingam United States
J.H.A.M. Kaanders Netherlands
Mark Sydenham United Kingdom
Annette Hogg Australia
Arnold M. Markoe United States
Robert S. Malyapa United States
Tetsuo Akimoto
Citations per year, relative to Tetsuo Akimoto Tetsuo Akimoto (= 1×) peers Robert S. Malyapa

Countries citing papers authored by Tetsuo Akimoto

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Akimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Akimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Akimoto more than expected).

Fields of papers citing papers by Tetsuo Akimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Akimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Akimoto. The network helps show where Tetsuo Akimoto may publish in the future.

Co-authorship network of co-authors of Tetsuo Akimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Akimoto. A scholar is included among the top collaborators of Tetsuo Akimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Akimoto. Tetsuo Akimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saeki, Koichi, Masaki Nakamura, Hidehiro Hojo, et al.. (2024). Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration. Cancer Immunology Research. 13(3). 353–364. 4 indexed citations
2.
Kawai, Kazushige, Daisuke Nakano, Toshiro Iizuka, et al.. (2024). Does Colorectal Stenting as a Bridge to Surgery for Obstructive Colorectal Cancer Increase Perineural Invasion?. SHILAP Revista de lepidopterología. 8(3). 195–203.
3.
Akimoto, Tetsuo, Hidefumi Aoyama, Melvin L.K. Chua, et al.. (2023). Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia. Advances in Radiation Oncology. 8(6). 101291–101291. 3 indexed citations
4.
Kageyama, Shun‐Ichiro, Riu Yamashita, Kosuke Tanaka, et al.. (2023). Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. Communications Biology. 6(1). 818–818. 13 indexed citations
5.
Kadota, Tomohiro, Atsushi Inaba, Hironori Sunakawa, et al.. (2023). Efficacy and safety of repeated endoscopic radial incision and cutting procedure for benign esophageal stricture. SHILAP Revista de lepidopterología. 11(3). E230–E236. 3 indexed citations
6.
Nakamura, Masaki, Shun‐Ichiro Kageyama, Hidenari Hirata, et al.. (2023). Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 116(5). 1085–1090. 3 indexed citations
7.
Okumura, Masayuki, Shun‐Ichiro Kageyama, Riu Yamashita, et al.. (2022). Comprehensive screening for drugs that modify radiation-induced immune responses. British Journal of Cancer. 126(12). 1815–1823. 3 indexed citations
8.
Kageyama, Shun‐Ichiro, Hidenari Hirata, Atsushi Motegi, et al.. (2021). Comparative analysis of the immune responses in cancer cells irradiated with X-ray, proton and carbon-ion beams. Biochemical and Biophysical Research Communications. 585. 55–60. 21 indexed citations
9.
Okumura, Masayuki, Hidehiro Hojo, Masaki Nakamura, et al.. (2021). Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease. Radiotherapy and Oncology. 161. 47–54. 8 indexed citations
10.
Sasaki, Akinori, Akihito Kawazoe, Saori Mishima, et al.. (2020). Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer. ESMO Open. 5(4). e000775–e000775. 30 indexed citations
11.
Kageyama, Shun‐Ichiro, Syuzo Kaneko, Ryuji Hamamoto, et al.. (2020). Identification of the mutation signature of the cancer genome caused by irradiation. Radiotherapy and Oncology. 155. 10–16. 5 indexed citations
12.
Okumura, Masayuki, Atsushi Motegi, Sadamoto Zenda, et al.. (2020). Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation. Head & Neck. 42(8). 1775–1782. 4 indexed citations
13.
Monden, Nobuya, Takahiro Asakage, Naomi Kiyota, et al.. (2019). A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition). Japanese Journal of Clinical Oncology. 49(7). 589–595. 25 indexed citations
14.
Kawaguchi, Hiroki, Toshinori Soejima, Naoya Ishibashi, et al.. (2019). National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group. Journal of Radiation Research. 60(5). 579–585. 4 indexed citations
15.
Kohno, Ryosuke, Wenhua Cao, Falk Poenisch, et al.. (2019). Biological Dose Comparison between a Fixed RBE and a Variable RBE in SFO and MFO IMPT with Various Multi-Beams for Brain Cancer. International Journal of Medical Physics Clinical Engineering and Radiation Oncology. 8(1). 32–45. 1 indexed citations
16.
17.
Isomura, Minoru, Natsuo Oya, Seiji Tachiiri, et al.. (2008). IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis. Clinical Cancer Research. 14(20). 6683–6689. 32 indexed citations
18.
Akimoto, Tetsuo. (2007). Radiobiological basis for hyperfractionated radiation therapy. Toukeibu Gan. 33(3). 276–279. 1 indexed citations
19.
Mitsuhashi, Norio, Hiroshi Sakurai, Tetsuya Takahashi, et al.. (1998). Does AK-2123 (Senazole) have sensitizing effects on radiation, cisplatin and hyperthermia under aerobic conditions in vitro?. PubMed. 18(5A). 3463–7. 4 indexed citations
20.
Hayakawa, Kazushige, Norio Mitsuhashi, Tetsuo Akimoto, et al.. (1996). The Effect of Overall Treatment Time of Radiation Therapy on Local Control of T1‐Stage Squamous Call Carcinoma of the Glottis. The Laryngoscope. 106(12). 1545–1547. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026